Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

CoreAge Rx vs Eden

By GLP-1 ScorecardUpdated

CoreAge Rx
Site position #1

Higher score

Eden
Site position #16

Lower score

Score comparison

CoreAge Rx has the higher recorded score — 89.5/100 to 81.6/100.

CoreAge Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

CoreAge Rx scores 89.5/100 (B+).

Before you choose

Before comparing the headline prices, the CoreAge Rx review and the Eden review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, CoreAge Rx vs Edessa and DrBrainRx vs Eden compare each of them with another graded program, and the list of alternatives to CoreAge Rx ranks the programs closest to CoreAge Rx on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueCoreAge Rx +7
92
85
Dose & formulationCoreAge Rx +2
88
86
Clinical oversightCoreAge Rx +38
93
55
Labs & monitoringEden +2
90
92
FulfillmentCoreAge Rx +2
95
93
Contract termsEden +23
67
90
CoreAge Rx · top barEden · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricCoreAge RxEden
WeighScore89.5/10081.6/100
GradeB+B−
Site position#1#16
SemaglutideProduct page from $79/mo; navigation $99. Confirm selected quote.Advertised $99/mo bundle; linked membership terms conflict—confirm checkout
TirzepatideFrom $129/mo advertised; confirm selected charge, supply and renewal.Advertised $129/mo bundle; linked membership terms conflict—confirm checkout
CoverageUS only; therapy-specific state restrictions applyAll 50 states
Brand-name accessNot confirmedYes
Oral / sublingualNot confirmedNot confirmed
CoreAge Rx

Site position #1 · B+

Strengths

  • Current product pages advertise starting prices of $79 for semaglutide and $129 for tirzepatide
  • Advertises the same price across doses and no membership fee
  • Publishes cancellation, fulfillment and refund rules and a way to request the assigned pharmacy

What to consider

  • Starting prices vary across public displays and do not establish a selected invoice or usable prescription supply
  • FAQ no-rebill and payment-timing statements differ from the subscription and order policy
  • FAQ promises a full rejection refund, while policy retains an applicable $50–$100 consultation fee after review begins
  • Refund policy makes orders final after approval and pharmacy transmission; Terms also refer to review completion/transmission with policy exceptions. Confirm the cutoff and separate thirty-day documentation limit.
  • Actual clinician, dispenser, physical compounder, lab cost and treatment-state eligibility need confirmation
Eden

Site position #16 · B−

FDAWarning letter issued to Eden Health International Inc. dba Eden in June 2026. See the FDA warning-letter database.

Strengths

  • Current compounded offer includes medication and support
  • Homepage also advertises branded prescription pathways; eligibility and cost require confirmation
  • Named pharmacy operation and partner network can be investigated

What to consider

  • Linked membership terms describe a separate fee model
  • Landing-page warranty and terms use different thresholds and conditions
  • FDA warning history remains relevant; a new offer does not establish resolution

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard